Efficacy of Physiotherapist-supervised Rehabilitation After Proximal Humerus Fracture

January 4, 2023 updated by: University of Aarhus

Efficacy of Physiotherapist-supervised Rehabilitation After Two-part Proximal Humerus Fractures Treated Non-operatively. A Randomised Controlled Trial

This study investigates the efficacy of physiotherapist-supervised training once per week during 10 weeks compared to home-based training during 10 weeks, after proksimal humerus fracture.

Study Overview

Detailed Description

Proximal humerus fracture is the third most common fracture in elderly people after hip and colles fracture, and are often caused by fall and osteoporosis. These fractures are highly related to morbidity and mortality among elderly people and consumes considerably health care resources. More than 70% of the proximal humerus fracture patients are over 60 years of age and 75% are female.

Only sparse evidence reveals to what extend the patients need rehabilitation and how it should be implemented in the treatment strategy.

In Denmark as well as in Finland the rehabilitation after proximal humerus fractures takes place in local centers in the municipalities, and the rehabilitation offered to the patients varies significantly. Currently in Denmark there are no national clinical guidelines to support the rehabilitation strategy.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Viborg, Denmark, 8800
        • Viborg Regional Hospital
      • Oslo, Norway
        • Oslo University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

•Low energy proximal humeral displaced (more than 5mm or 30 degrees) two-part fracture where fracture line emerges through the surgical (or anatomical) neck, treated non-operatively

Exclusion Criteria:

  • Refuse to participate in the study
  • Younger than 60 years old
  • Non-independent
  • Demented
  • Does no understand written and spoken guidance in local language
  • Pathological fracture or previous fracture in the same proximal humerus
  • Other operational injuries in the same upper limb
  • Major nerve injury (e.g. Complete radialis- or delta palsy)
  • Open fracture
  • Multi-trauma patient
  • Fracture dislocation or head splitting fracture
  • Undisplaced fracture
  • Isolated tuberculum fracture
  • Fracture has no precondition to ossify by conservative treatment (no bony contact between fracture parts or the humeral shaft is in contact with the articular surface)
  • Treating surgeon considers patient unsuitable to attend the study on medical basis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Home-based training
10 weeks of home-based training with no supervision of a physiotherapist
The intervention is home-based training during 10 weeks
Other: Physiotherapist-supervised training
Physiotherapist-supervised training once per week during 10 weeks in addition to home-based training
The intervention is physiotherapist-supervised training once per week during 10 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Disability of the Arm, Shoulder and Hand (DASH)
Time Frame: Measured at 3 months after fracture

Patient reported outcome measure of physical function in the upper extremity. Measures on a 0-100 scale, where a higher score indicates greater disability.

The scores will be compared between the 2 groups

Measured at 3 months after fracture

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Disability of the Arm, Shoulder and Hand (DASH)
Time Frame: Measured at baseline and after 12 months

Patient reported outcome measure of physical function in the upper extremity. Measures on a 0-100 scale, where a higher score indicates greater disability.

The scores will be compared between the 2 groups

Measured at baseline and after 12 months
Constant Murley Shoulder Score
Time Frame: Measured after 3 and 12 months.
Subjective and objective measurement of the shoulder function. Measures on a 0-100 scale, where a lower score indicates greater disability. The scores will be compared between the 2 groups
Measured after 3 and 12 months.
15-dimentional health-realted quality of life instrument (15D)
Time Frame: Measured at baseline, after 3 and 12 months

Patient reported outcome measure of health related quality of life. A set of utility or preference weights is used to generate the 15D score (single index number) on a 0-1 scale, where a higher score indicates a poor health related quality of life.

The scores will be compared between the 2 groups

Measured at baseline, after 3 and 12 months
Pain catastrophizing Scale
Time Frame: Measured at baseline, after 3 and 12 months

Patient reported outcome measure. Measures on a 0-53 scale, where a higher score indicates a higher levels of pain catastrophizing thinking.

The scores will be compared between the 2 groups. Also the correlation with DASH scores will be investigated

Measured at baseline, after 3 and 12 months
Generel Self-Efficacy scale
Time Frame: Measured at baseline, after 3 and 12 months

Patient reported outcome measure. Measures on a 10-40 scale, where a higher score indicates a higher degree of self-efficacy.

The scores will be compared between the 2 groups. Also the correlation with DASH scores will be investigated

Measured at baseline, after 3 and 12 months
Accelerometer based activity in the upper extremity
Time Frame: Measured at 3 and 12 months

The patient is wearing a censor above the elbow on both arms, that measures the level of upper extremity activity for three consecutive days. It measures the number of movements under and above shoulder hight and classify them into either high or low intensity movements.

The asymmetry between the fractured and the healthy arm will be estimated and compared between the groups.

Measured at 3 and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Follow up of the decliners
Time Frame: Measured at baseline and 3 months
Patients declining to participate in the randomised trial will be invited to follow up visits, consisting of x-rays and identical questionnaires as used in the RCT
Measured at baseline and 3 months
Cost-effectiveness
Time Frame: After 12 months
A cost-effectiveness analysis (QALY) of the two training modalities will be performed and a ratio will be estimated.
After 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 24, 2018

Primary Completion (Actual)

January 25, 2022

Study Completion (Actual)

January 25, 2022

Study Registration Dates

First Submitted

April 3, 2018

First Submitted That Met QC Criteria

April 13, 2018

First Posted (Actual)

April 17, 2018

Study Record Updates

Last Update Posted (Actual)

January 5, 2023

Last Update Submitted That Met QC Criteria

January 4, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ProxHumRehab

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Humeral Fracture

Clinical Trials on Home-based training

3
Subscribe